Search - tctmd.com

Displaying 1 - 20 of 343

Sort: Relevancy | Date

Presentation THT 2026

Interatrial Shunts: Reflections of a Seasoned Practitioner

Presenter: John R. Teerlink

March 04, 2026

Presentation THT 2026

Longterm Outcomes With Corvia Shunt

Presenter: Sanjiv J. Shah

March 04, 2026

Presentation THT 2026

Experiences With Implant-Free Interatrial Shunting

Presenter: James E. Udelson

March 04, 2026

Presentation THT 2026

Do We Need Shunts of Different Sizes?

Presenter: Liviu Klein

March 04, 2026

Presentation THT 2026

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Presenter: Ryan J. Tedford

March 04, 2026

Presentation THT 2026

Evaluation of RV Function in Shunt Trials — Does it Matter?

Presenter: Joao L. Cavalcante

March 04, 2026

Presentation THT 2026

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

Response to left atrial to coronary sinus shunting in patients with heart failure and atrial fibrilllation

Presenter: JoAnn Lindenfeld

March 03, 2026

Presentation THT 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Presenter: Jozef Bartunek

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Presentation THT 2026

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Presenter: David Niehaus

March 02, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Todd Neale

December 05, 2025

Presentation TCT 2025

Primary Results from the ATHENS-HF Trial: An FIH Study of the Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt (Adona Medical)

Presenter: Gregg W. Stone

October 28, 2025

Presentation TCT 2025

The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT

Presenter: Dean J. Kereiakes

October 28, 2025

Advertisement

Interatrial Shunts: Reflections of a Seasoned Practitioner

Longterm Outcomes With Corvia Shunt

Experiences With Implant-Free Interatrial Shunting

Do We Need Shunts of Different Sizes?

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Evaluation of RV Function in Shunt Trials — Does it Matter?

Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF

Response to left atrial to coronary sinus shunting in patients with heart failure and atrial fibrilllation

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

TCTMD’s Top 10 Most Popular Stories for February 2026

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

THT 2026: What to Expect in Boston

TCTMD’s Top 10 Most Popular Stories for December 2025

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Primary Results from the ATHENS-HF Trial: An FIH Study of the Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt (Adona Medical)

The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content